ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
12.80
+0.26 (2.07%)
Sep 17, 2026, 2:53 PM EDT - Market open
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.33 billion as of September 17, 2026. Its market cap has increased by 25.33% in one year.
Market Cap
1.33B
Enterprise Value
1.07B
1-Year Change
25.33%
Ranking
Category
Stock Price
$12.80
ChartMarket Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.33B, an increase of 78.81%. That is a compound annual growth rate of 9.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 1.33B | 66.54% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.36B |
| Maze Therapeutics | 1.35B |
| Savara | 1.34B |
| Cullinan Therapeutics | 1.32B |
| Vor Biopharma | 1.32B |
| Ultragenyx Pharmaceutical | 1.28B |
| Aktis Oncology | 1.25B |
| Omeros | 1.24B |